The levels of ABCA4 expression achieved following dual vector delivery significantly altered the biochemistry of the injected retina such that reduction in the levels of bisretinoids, which characteristically build up in Stargardt disease, were detected in addition to an associated reduction in 790 nm autofluorescence in treated eyes. Here, ABCA4 is linked to Stargardt disease.